scholarly journals miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1

RSC Advances ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. 5234-5243 ◽  
Author(s):  
Xiang Song ◽  
Fanyi Kong ◽  
Zhenfeng Zong ◽  
Mingming Ren ◽  
Qingjun Meng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Drug Resistance ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Major Obstacle ◽  
Small Cell Lung ◽  
Cisplatin Sensitivity

Drug resistance is a major obstacle in the treatment of non-small cell lung cancer (NSCLC).

Silence of  lncRNA UCA1 rescues drug resistance of cisplatin to non–small‐cell lung cancer cells

2019 ◽  
Vol 120 (6) ◽  
pp. 9243-9249 ◽  
Author(s):  
Xiaojing Liu ◽  
Zhisheng Huang ◽  
Wei Qian ◽  
Qing Zhang ◽  
Jian Sun
Keyword(s):  
Lung Cancer ◽  
Drug Resistance ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung

Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells

2018 ◽  
Vol 83 (3) ◽  
pp. 399-410 ◽  
Author(s):  
Yu Hua Quan ◽  
Ji-Young Lim ◽  
Byeong Hyeon Choi ◽  
Yeonho Choi ◽  
Young Ho Choi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
Cisplatin Sensitivity
Sign in / Sign up

Export Citation Format

Share Document